Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane
Cochrane · University Hospitals Bristol NHS Foundation Trust · +14 more institutions
Abstract
A systematic review identifies, appraises and synthesises all the empirical evidence from studies that meet prespecified eligibility criteria to answer a specific research question. As part of the appraisal, researchers use explicit methods to assess risk of bias in the results' from included studies that contribute to the review's findings, to improve our confidence in the review's conclusions. Randomised controlled trials included in Cochrane Reviews have used a specific risk of bias tool to assess these included studies since 2008. In 2019, a new version of this tool, Risk of Bias 2 (RoB 2), was launched to improve its usability and to reflect current understanding of how the causes of bias can influence…
Citation impact
- FWCI
- 51.32
- Percentile
- 100%
- References
- 19
Authors
7- EFElla Flemyng
Cochrane
- THTheresa HM Moore
University Hospitals Bristol NHS Foundation Trust, University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust
- IBIsabelle Boutron
Inserm, Université Paris Cité, Sorbonne Université, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Université Sorbonne Paris Nord, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôtel-Dieu de Paris
- JPJulian P. T. Higgins
University Hospitals Bristol NHS Foundation Trust, University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust
- AHAsbjørn Hróbjartsson
University of Southern Denmark, Odense University Hospital, Cochrane
Topics & keywords
- Systematic review
- Usability
- Cochrane Library
- Medicine
- Randomized controlled trial
- MEDLINE
- Meta-analysis
- Medical physics